Applied Physiology and Kinesiology, University of Florida, USA.
Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1515-24. doi: 10.1152/ajpheart.00585.2010. Epub 2010 Sep 10.
Doxorubicin (Dox) is an antitumor agent used in cancer treatment, but its clinical use is limited due to cardiotoxicity. Although exercise training can defend against Dox-mediated cardiac damage, the means for this cardioprotection remain unknown. To investigate the mechanism(s) responsible for exercise training-induced cardioprotection against Dox-mediated cardiotoxicity, we tested a two-pronged hypothesis: 1) exercise training protects against Dox-induced cardiotoxicity by preventing Dox-mediated mitochondrial damage/dysfunction and increased oxidative stress and 2) exercise training-induced cardiac expression of the inducible isoform of the 70-kDa heat shock protein 72 (HSP72) is essential to achieve exercise training-induced cardioprotection against Dox toxicity. Animals were randomly assigned to sedentary or exercise groups and paired with either placebo or Dox treatment (i.e., 20 mg/kg body wt ip Dox hydrochloride 24 h before euthanasia). Dox administration resulted in cardiac mitochondrial dysfunction, activation of proteases, and apoptosis. Exercise training increased cardiac antioxidant enzymes and HSP72 protein abundance and protected cardiac myocytes against Dox-induced mitochondrial damage, protease activation, and apoptosis. To determine whether exercise-induced expression of HSP72 in the heart is required for this cardioprotection, we utilized an innovative experimental strategy that successfully prevented exercise-induced increases in myocardial HSP72 levels. However, prevention of exercise-induced increases in myocardial HSP72 did not eliminate the exercise-induced cardioprotective phenotype that is resistant to Dox-mediated injury. Our results indicate that exercise training protects against the detrimental side effects of Dox in cardiac myocytes, in part, by protecting mitochondria against Dox-mediated damage. However, this exercise-induced cardioprotection is independent of myocardial HSP72 levels. Finally, our data are consistent with the concept that increases in cardiac mitochondrial antioxidant enzymes may contribute to exercise-induced cardioprotection.
阿霉素(Dox)是一种用于癌症治疗的抗肿瘤药物,但由于其心脏毒性,其临床应用受到限制。尽管运动训练可以预防阿霉素引起的心脏损伤,但这种心脏保护的机制尚不清楚。为了研究运动训练对阿霉素引起的心脏毒性的保护机制,我们提出了两个假设:1)运动训练通过防止阿霉素引起的线粒体损伤/功能障碍和增加氧化应激来预防阿霉素引起的心脏毒性;2)运动训练诱导的 70kDa 热休克蛋白 72(HSP72)的诱导型同工酶在心脏中的表达对于实现运动训练对阿霉素毒性的心脏保护是必不可少的。动物被随机分配到安静或运动组,并与安慰剂或阿霉素治疗配对(即,在安乐死前 24 小时腹腔注射 20mg/kg 体重的盐酸阿霉素)。阿霉素给药导致心脏线粒体功能障碍、蛋白酶激活和细胞凋亡。运动训练增加了心脏抗氧化酶和 HSP72 蛋白的丰度,并保护心脏肌细胞免受阿霉素引起的线粒体损伤、蛋白酶激活和凋亡。为了确定心脏中 HSP72 的运动诱导表达是否是这种心脏保护所必需的,我们利用了一种创新的实验策略,成功地防止了运动诱导的心肌 HSP72 水平升高。然而,防止运动诱导的心肌 HSP72 增加并没有消除运动诱导的心脏保护表型,该表型对阿霉素介导的损伤具有抗性。我们的结果表明,运动训练通过保护线粒体免受阿霉素介导的损伤来预防心肌细胞中阿霉素的有害副作用,部分原因是通过保护线粒体免受阿霉素介导的损伤。然而,这种运动诱导的心脏保护与心肌 HSP72 水平无关。最后,我们的数据与增加心脏线粒体抗氧化酶可能有助于运动诱导的心脏保护的概念一致。